» Articles » PMID: 12490295

Hedgehog Signaling in Pancreas Development

Overview
Journal Mech Dev
Publisher Elsevier
Date 2002 Dec 20
PMID 12490295
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Hedgehog proteins are secreted molecules that bind to their cell surface receptors to elicit concentration dependent responses essential for numerous tissue patterning and cell differentiation events during embryogenesis. However, during early stages of pancreas organogenesis, hedgehog signaling has been shown to inhibit tissue morphogenesis and cell differentiation. By contrast, recent cell culture studies indicate that an active hedgehog pathway might be required for maintenance of adult endocrine cell functions. This review describes our current understanding of the requirement of hedgehog signaling during pancreas morphogenesis and cell differentiation and discusses how individual hedgehog genes might act at various stages to ensure proper pancreas development and organ function.

Citing Articles

Role of Hedgehog Signaling Pathways in Multipotent Mesenchymal Stem Cells Differentiation.

Wu M, Mi J, Qu G, Zhang S, Jian Y, Gao C Cell Transplant. 2024; 33:9636897241244943.

PMID: 38695366 PMC: 11067683. DOI: 10.1177/09636897241244943.


Heterozygous missense variant in GLI2 impairs human endocrine pancreas development.

Mueller L, Isaacson A, Wilson H, Salowka A, Tay I, Gong M Nat Commun. 2024; 15(1):2483.

PMID: 38509065 PMC: 10954617. DOI: 10.1038/s41467-024-46740-8.


Manipulation of Sonic Hedgehog Signaling Pathway in Maintenance, Differentiation, and Endocrine Activity of Insulin-Producing Cells: A Systematic Review.

Dayer D, Bayati V, Ebrahimi M Iran J Med Sci. 2024; 49(2):65-76.

PMID: 38356490 PMC: 10862108. DOI: 10.30476/ijms.2023.95425.2678.


eQTL mapping in fetal-like pancreatic progenitor cells reveals early developmental insights into diabetes risk.

Nguyen J, Arthur T, Fujita K, Salgado B, Donovan M, Matsui H Nat Commun. 2023; 14(1):6928.

PMID: 37903777 PMC: 10616100. DOI: 10.1038/s41467-023-42560-4.


Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant.

Shilleh A, Russ H Cells. 2023; 12(5).

PMID: 36899834 PMC: 10000642. DOI: 10.3390/cells12050698.